NCT05954949

Brief Summary

The detection of adenomas is the basis for the follow-up of patients with familial adenomatous polyposis, after colectomy, with a remnant rectum or an ileal pouch. The optimal method for the adenomas detection is not defined yet. Despite the proven effectiveness of indigo-carmine in different indications dye chromoendoscopy is not used in a consensual way at the international level. The situation of the ileal pouch is specific as adenomas have a usually flat shape and are much more difficult to identify than in the situation of a remnant rectum, even in the situation of \> 5 mm adenomas that should be resected. Our hypothesis is that indigo-carmine can improve adenomas detection, including \> 5 mm adenomas, in patients with a an ileal pouch after colectomy improving the effectiveness of surveillance programs and potentially reducing the risk of cancer in this population.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2024

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 11, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 20, 2023

Completed
1.1 years until next milestone

Study Start

First participant enrolled

September 9, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 11, 2025

Completed
Last Updated

September 25, 2023

Status Verified

September 1, 2023

Enrollment Period

1 year

First QC Date

July 11, 2023

Last Update Submit

September 21, 2023

Conditions

Keywords

familial adenomatous polyposisIleoanal pouch/reservoiradenomaschromoendoscopyindigocarminecolectomy

Outcome Measures

Primary Outcomes (1)

  • Average number of ileal pouch/reservoir adenomas

    Average number of ileal pouch/reservoir adenomas detected according to the endoscopic mode (staining or not, virtual or not) based on a paired review of the films with final consensus in case of discordance

    6 months after colonoscopy

Study Arms (1)

Ileoanal pouch adenomas detection assessment

Every patient who needs follow up lower digestive examination for familial adenomatous polyposis after colectomy can join this study with ileal pouch adenomas detection by experienced endoscopist.

Procedure: Adenomas detection rate with the different observation methods

Interventions

Films performed in white light high definition, NBI and indigo-carmine dye, will be compared blindly to detecte number of adenomas with the different observation methods

Ileoanal pouch adenomas detection assessment

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults with familial adenomatous polyposis after colectomy

You may qualify if:

  • Patients with familial adenomatous polyposis
  • Ileo-anal anastomosis with pouch reservoir
  • Quality of the final preparation = 3 (excellent) on the studied area
  • Films made under optimal conditions for the 3 staining methods

You may not qualify if:

  • Patient with no familial adenomatous polyposis
  • Patient without Ileo-anal anastomosis reservoir
  • Insufficient quality of the final preparation \<3
  • Absence of films made under optimal conditions for the 3 staining methods

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Adenomatous PolypsAdenomatous Polyposis ColiAdenoma

Condition Hierarchy (Ancestors)

Neoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsColorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplastic Syndromes, HereditaryDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesIntestinal PolyposisGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator, Medical Doctor

Study Record Dates

First Submitted

July 11, 2023

First Posted

July 20, 2023

Study Start

September 9, 2024

Primary Completion

September 10, 2025

Study Completion

September 11, 2025

Last Updated

September 25, 2023

Record last verified: 2023-09